|
Sign In to gain access to subscriptions and/or personal tools.
|
Schedule 11 — impact on treating erectile dysfunction
Geoff Hackett
Department of Urology, Good Hope Hospital, Rectory Road, Sutton Coldfield, West Midlands, B75 7RR, UK, ghac876762{at}aol.com
Since 1998, NHS therapy for erectile dysfunction (ED) has only been available under schedule 11 regulations. This involves restriction to certain medical conditions and restrictions of the quantity of medications. A new category was introduced, namely a patient confirmed by a consultant as suffering from `severe distress'. Recent evidence suggests that ED is closely related to many important men's health issues and that restricting access to therapy in this way is both wasteful of resources and leading to missed healthcare opportunities. In the light of recent evidence, certain aspects of schedule 11 need to be reviewed.
Key Words: schedule 11 • erectile dysfunction.
References
- Dunn KM, Croft PR, Hackett GI Sexual problems: a study of the prevalence and need for health care in the general population. Fam Pract 1998;15:519-24.[Abstract/Free Full Text]
- Dunn KM, Croft PR, Hackett GI Association of sexual problems with social, psychological, and physical problems in men and women: a cross sectional population survey. J Epidemiol Community Health 1999;53: 144-8.[Abstract]
- Central Office of Information Health Impotence Consultation Document, 7th May 1999, Number 0274.
- Johnson A., Wadsworth J. et al. Sexual Attitudes and Lifestyle Survey UK 1990-91. 1994.
- Central Office of Information Health - Impotence Consultation Document. November 2001.
- Hackett GI, Milledge D. A 12-month follow up of 260 patients attending a UK erectile dysfunction clinic. Poster 160, ESSIR, Rome, October 2001.
- Wilson E., McKeen E., Scuffham P., Brown M., Hackett G. The NHS cost of managing ED. Poster presentation, EAU, Birmingham, Feb 2002.
- Kirby M., Jackson G., Betteridge J., Friedli K. Is erectile dysfunction a marker for cardiovascular disease? Int J Clin Pract 2001;55:614-18.[Web of Science][Medline]
[Order article via Infotrieve]
- O'Kane PD, Jackson G. Erectile dysfunction: Is there silent obstructive coronary artery disease? Int J Clin Pract 2001;55:219-20.[Web of Science][Medline]
[Order article via Infotrieve]
- Smith GD, Frankel S., Yarnell J. Sex and death: are they related? Findings from the Caerphilly cohort study. BMJ 1997;315:1641-4.[Abstract/Free Full Text]
- Seidman SN, Roose SP, Menza MA, Shabsigh R., Rosen RC Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry 2001; 158:1623-30.[Abstract/Free Full Text]
- Goldstein I., Lue TF, Padma-Nathan H., Rosen RC, Steers WD, Wicker PA Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;338:1397-404.[Abstract/Free Full Text]
- Hackett G. The cost effective management of erectile dysfunction. Men's Health 2002;1:84-6.
The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 4,
315-318 (2002)
DOI: 10.1177/14746514020020041701
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
K. J Snow
Erectile dysfunction in patients with diabetes mellitus -- advances in treatment with phosphodiesterase type 5 inhibitors
The British Journal of Diabetes & Vascular Disease,
July 1, 2002;
2(4):
282 - 287.
[Abstract]
[PDF]
|
|
|
|
|
